Arrowhead Research Corp

Type: Company
Name: Arrowhead Research Corp
First reported 7 hours ago - Updated 7 hours ago - 1 reports

BioNews [9.30.14]

Top News HeadlineCompanyType Gilead Sciences, Inc. Will Employ 500 People At New SoCal Campus Gilead Sciences, Inc.Jobs Acasti Pharma Announces Positive Top-Line Pharmacokinetic Results Acasti Pharma Inc.Study Results The Washington Institute ... [Published eClinical Trends - 7 hours ago]
First reported 13 hours ago - Updated 13 hours ago - 1 reports

Arrowhead Expands Management Team with Appointment of Susan Boynton as Vice President Global Regulatory Affairs

--Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that Susan Boynton has been appointed Vice President, Global Regulatory Affairs. In this role, Ms. Boynton will have overall ... [Published Scottrade - 13 hours ago]
First reported Sep 25 2014 - Updated Sep 26 2014 - 2 reports

Arrowhead Research Has Returned 7.9% Since SmarTrend Recommendation (ARWR)

Written on Thu, 09/25/2014 - 6:29pmBy Nick RussoSmarTrend identified an Uptrend for Arrowhead Research ( NASDAQ:ARWR ) on August 14th, 2014 at $13.88. In approximately 1 month, Arrowhead Research has returned 7.89% as of today's recent price of $14. ... [Published Comtex SmarTrend - Sep 26 2014]
First reported Sep 19 2014 - Updated Sep 19 2014 - 3 reports

Arrowhead to Present at BioCentury’s NewsMakers in the Biotech Industry Conference

Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that Bruce Given, M.D., Arrowhead’s chief operating officer, will present at BioCentury’s 21 st Annual NewsMakers…Click to ... [Published Fort Mills Times - Sep 19 2014]
First reported Sep 19 2014 - Updated Sep 19 2014 - 1 reports

Arrowhead to Present at BioCentury's NewsMakers in the Biotech Industry Conference

--Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that Bruce Given, M.D., Arrowhead's chief operating officer, will present at BioCentury's 21(st) Annual NewsMakers in the ... [Published Scottrade - Sep 19 2014]
First reported Sep 17 2014 - Updated Sep 18 2014 - 3 reports

Arrowhead Research Shares Up 13.9% Since SmarTrend's Buy Recommendation (ARWR)

Written on Thu, 09/18/2014 - 12:50pmBy David DiazSmarTrend identified an Uptrend for Arrowhead Research ( NASDAQ:ARWR ) on August 14th, 2014 at $13.88. In approximately 1 month, Arrowhead Research has returned 13.95% as of today's recent price of $1 ... [Published Comtex SmarTrend - Sep 18 2014]
First reported Sep 15 2014 - Updated Sep 15 2014 - 1 reports

Shares of Arrowhead Research Under Pressure, Down 5.9%

Arrowhead Research (NASDAQ:ARWR) is one of today's biggest movers, down 5.9% to $15.55. The Dow Jones Industrial Average is now trading fractionally lower to 16,985 and the S&P is trading 0.2% lower to 1,981. ... [Published Individual.com - Sep 15 2014]
First reported Sep 11 2014 - Updated Sep 11 2014 - 1 reports

Arrowhead Research Shares Up 22.4% Since SmarTrend's Buy Recommendation (ARWR)

SmarTrend identified an Uptrend for Arrowhead Research (NASDAQ:ARWR) on August 14th, 2014 at $13.88. In approximately 4 weeks, Arrowhead Research has returned 22.45% as of today's recent price of $16.99. ... [Published Individual.com - Sep 11 2014]
First reported Sep 11 2014 - Updated Sep 11 2014 - 2 reports

3 Biotech Breakout Charts That Could See More Upside

09/11/14 - 01:47 PM EDTNEW YORK ( TheStreet ) -- Strong charts continue to be found in this uncertain market, especially in the biotechs. Here are three to watch for more upside.Arrowhead Research   ( ARWR ) is in a bottoming pattern. It pulled back to ... [Published TheStreet.com - Sep 11 2014]
First reported Sep 09 2014 - Updated Sep 09 2014 - 1 reports

Arrowhead Research Shares Climbing Higher, Up 4.1%

Written on Tue, 09/09/2014 - 11:11amBy Shiri GuptaArrowhead Research ( NASDAQ:ARWR ) is one of today's notable stocks on the rise, up 4.1% to $17.37. The S&P is currently trading 0.4% lower to 1,993 and the Dow Jones Industrial Average is trading 0.5% ... [Published Comtex SmarTrend - Sep 09 2014]
First reported Sep 05 2014 - Updated Sep 05 2014 - 2 reports

FRIDAY'S ETF MOVERS : Xlu, xbi

In trading on Friday, the Utilities Select Sector SPDR Fund ETF (XLU) is outperforming other ETFs, up about 0.8% on the day. Components of that ETF showing particular strength include shares of Xcel Energy (XEL), up about 1.5% and shares of PG&E (PCG), ... [Published 4 Traders - Sep 05 2014]
First reported Sep 03 2014 - Updated Sep 04 2014 - 2 reports

Top 5 Companies in the Healthcare Sector with the Best Relative Performance (CLDX, OREX, ARWR, CI, WLP)

Written on Thu, 09/04/2014 - 11:25amBy Amy SchwartzWe looked at the Healthcare sector and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at today's ... [Published Comtex SmarTrend - Sep 04 2014]

Quotes

...are excited to have her join the Arrowhead management team," said Christopher Anzalone, Ph D , Arrowhead's President and Chief Executive Officer. "Her experience leading regulatory efforts through the development and commercialization process will be extremely valuable to Arrowhead as we move ARC-520 and ARC-AAT forward and, importantly, as we continue to expand our pipeline of RNAi therapeutics."
"We rate VERTEX PHARMACEUTICALS INC (VRTX) a HOLD. The primary factors that have impacted our rating are mixed ? some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance for this stock relative to most other stocks. The company's strengths can be seen in multiple areas, such as its solid stock price performance and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share, unimpressive growth in net income and disappointing return on equity."
Frank R asks, "I wrote you a few months back regarding Galena Biopharma"
"We rate ARROWHEAD RESEARCH CORP (ARWR) a SELL. This is driven by several weaknesses, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income and weak operating cash flow." You can view the full analysis from the report here: ARWR Ratings Report

More Content

All (112) | News (75) | Reports (0) | Blogs (30) | Audio/Video (0) | Fact Sheets (0) | Press Releases (7)
sort by: Date | Relevance
BioNews [9.30.14] [Published eClinical Trends - 7 hours ago]
Arrowhead Expands Management Team with Appointm... [Published Scottrade - 13 hours ago]
Biotech Stock Mailbag: ProQR, Vertex Pharma, Te... [Published TheStreet.com - Sep 26 2014]
Biotech Stock Mailbag: ProQR, Vertex Pharma, Te... [Published The Street Latest - Sep 26 2014]
Arrowhead Research Has Returned 7.9% Since Smar... [Published Comtex SmarTrend - Sep 26 2014]
Arrowhead Research Crosses Below its 10-... [Published Financial News Network online - Sep 25 2014]
Arrowhead to Present at BioCentury’s NewsMakers... [Published Fort Mills Times - Sep 19 2014]
Arrowhead to Present at BioCentury's NewsMakers... [Published Scottrade - Sep 19 2014]
Arrowhead to Present at BioCentury’s NewsMakers... [Published 4 Traders - Sep 19 2014]
Arrowhead to Present at BioCentury’s NewsMakers... [Published Business Wire Health News - Sep 19 2014]
Arrowhead Research Shares Up 13.9% Since SmarTr... [Published Comtex SmarTrend - Sep 18 2014]
Arrowhead Research Shares Up 13.9% Since SmarTr... [Published Individual.com - Sep 18 2014]
Leading Health Care Stock for Small-Cap Stars i... [Published Equities.com - Sep 17 2014]
Leading Small-Cap Stars Health Care Stock for S... [Published Equities.com - Sep 17 2014]
Arrowhead Research Corp Receives “Outperform” R... [Published Mideast Time - Sep 17 2014]
Stock Analysts’ Ratings Reiterations for Septem... [Published American Banking News - Sep 17 2014]
Top 5 Companies in the Healthcare Sector with t... [Published Comtex SmarTrend - Sep 16 2014]
Critical Alerts For Intel, Zynga, Isis Pharmace... [Published PR Newswire: Financial Services - Sep 16 2014]
Shares of Arrowhead Research Under Pressure, Do... [Published Individual.com - Sep 15 2014]
3 Biotech Breakout Charts That Could See More U... [Published TheStreet.com - Sep 11 2014]
3 Biotech Breakout Charts That Could See More U... [Published The Street Latest - Sep 11 2014]
Arrowhead Research Shares Up 22.4% Since SmarTr... [Published Individual.com - Sep 11 2014]
Arrowhead Research Shares Climbing Higher, Up 4.1% [Published Comtex SmarTrend - Sep 09 2014]
Relatively Good Performance Detected in Shares ... [Published Comtex SmarTrend - Sep 08 2014]
FRIDAY'S ETF MOVERS : Xlu, xbi [Published 4 Traders - Sep 05 2014]
Friday's ETF Movers: XLU, XBI [Published Forbes.com - Sep 05 2014]
Arrowhead Research Corp Heads Higher After Brea... [Published Benzinga.com - Sep 04 2014]
Top 5 Companies in the Healthcare Sector with t... [Published Comtex SmarTrend - Sep 04 2014]
18.4% Return Seen to Date on SmarTrend Arrowhea... [Published Individual.com - Sep 04 2014]
Technical Data on Biotech Stocks - ARIAD Pharma... [Published Financial Services - Sep 04 2014]
1 2 3 4
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
BioNews [9.30.14] [Published eClinical Trends - 7 hours ago]
Top News HeadlineCompanyType Gilead Sciences, Inc. Will Employ 500 People At New SoCal Campus Gilead Sciences, Inc.Jobs Acasti Pharma Announces Positive Top-Line Pharmacokinetic Results Acasti Pharma Inc.Study Results The Washington Institute ...
Arrowhead to Present at BioCentury’s NewsMakers... [Published Business Wire Health News - Sep 19 2014]
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research will present at BioCentury’s 21st Annual NewsMakers in the Biotech Industry conference on September 26, 2014 at 10:30 a.m. EDT in New York ...
Critical Alerts For Intel, Zynga, Isis Pharmace... [Published PR Newswire: Financial Services - Sep 16 2014]
CHICAGO, Sept. 16, 2014 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for INTC, ZNGA, ISIS, ARWR and MNKD.To see what our analysts have discovered about a particular stock, read the InvestorsObserver's PriceWatch Alert by selecting ...
Upcoming Conferences, Market Activity, Drug App... [Published PR Newswire: Entertainment & Media - Aug 29 2014]
NEW YORK, August 29, 2014 /PRNewswire/ --Today, Analysts Review released its research reports regarding Mallinckrodt plc (NYSE: MNK), Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), Kite Pharma, Inc. (NASDAQ: KITE), Bristol-Myers Squibb Company (NYSE: ...
Critical Alerts For Arrowhead Research, Isis Ph... [Published PR Newswire: Financial Services - Aug 27 2014]
CHICAGO, Aug. 27, 2014 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ARWR, ISIS, MOBL, JPM and VIAB.To see what our analysts have discovered about a particular stock, read the InvestorsObserver's PriceWatch Alert by selecting ...
1 2 3 4 5 6

Press Releases

sort by: Date | Relevance
Technical Data on Biotech Stocks - ARIAD Pharma... [Published Financial Services - Sep 04 2014]
Technical Data on Biotech Stocks -- Arrowhead R... [Published Financial Services - Aug 04 2014]
SEC Filings, Positive Trial Results, Technical ... [Published Financial Services - Jul 18 2014]
Technical Updates, License Agreements, and Acqu... [Published Financial Services - Jul 08 2014]
Clinical Studies, Trials Results, Appointments,... [Published Financial Services - Jun 27 2014]
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.